Mainz Biomed B.V.'s market cap is currently ―. The company's EPS TTM is $-1.861; its P/E ratio is -0.51; Mainz Biomed B.V. is scheduled to report earnings on September 4, 2024, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Jun 22	Dec 21	Jun 21
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 7.07M	$ 17.14M	$ 26.01M	$ 8.73M	$ 195.16K
Total Assets	$ 15.41M	$ 20.24M	$ 27.62M	$ 10.04M	$ 734.47K
Total Debt	$ 6.39M	$ 1.32M	$ 2.49M	$ 636.27K	$ 675.88K
Net Debt	$ -680.31K	$ -15.82M	$ -23.52M	$ -8.09M	$ 480.72K
Total Liabilities	$ 12.16M	$ 6.14M	$ 3.84M	$ 3.68M	$ 3.15M
Stockholders Equity	$ 3.25M	$ -4.15M	$ 23.77M	$ 6.36M	$ -2.41M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in USD

Mainz Biomed B.V. Earnings and Revenue History

Income Statement >

Mainz Biomed B.V. Debt to Assets

Balance Sheet >

Mainz Biomed B.V. Cash Flow

Cash Flow >

Mainz Biomed B.V. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing